Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Publication year range
1.
International Eye Science ; (12): 1262-1266, 2022.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-934995

ABSTRACT

AIM: The clinical outcomes of unilateral single-focal intraocular len(SIOL), contralateral implanted multifocal IOL(MIOL)and the SIOL was implanted in binoculus were compared.METHODS: There were 60 cases with 120 eyes age-related cataract patients in January 2019 to January 2021 underwent phacoemulsification and IOL implantation in Chengdu Aier Eye Hospital. The SIOL has been implanted in the dominant eyes, all patients were divided into three groups according to the types of IOL implanted in the contralateral non-dominant eyes, among them, there were 36 eyes of 18 cases in group A with non-dominant eyes implanted MIOL(SBL-3); 38 eyes of 19 cases in group B were implanted MIOL(SN6AD1)in non-dominant eyes. SIOL was implanted in all 46 eyes of 23 cases of control group. After operation at 3mo,the results of binocular vision and visual quality of the three groups were evaluated and compared.RESULTS: After operationat 3mo, there was no difference in the uncorrected distance vision and corrected distance vision, uncorrected medium vision and corrected near vision among the three groups(P<0.05).The uncorrected near visual acuity and corrected intermediate visual acuity of both eyes in groups A and B were significantly improved in both groups compared with the control group(P<0.05). The scores of Catquest 9SF-CN scale showed that the quality of life of patients in group A and group B(11.11±1.323, 11.89±1.883 scores)was better than that in the control group(14.65±1.722 scores, both P<0.05). The rate of lens removal in group A, B and control group were 88.9%, 84.2% and 39.1%, respectively, and the rate of lens removal in group A was significantly higher than that in the control group(P<0.0167).CONCLUSION: Dominant eye implantation of SIOL in patients with cataract and contralateral non-dominant eye implantation of MIOL(SBL-3/SN6AD1)can obtain better full-range visual acuity than binoculus, less postoperative adverse visual symptoms, and higher patient disengagement rate and satisfaction.

2.
Int J Biol Macromol ; 163: 232-239, 2020 Nov 15.
Article in English | MEDLINE | ID: mdl-32561283

ABSTRACT

5-Fluorouracil (5-Fu) is an effective anticarcinogenic agent, however, continuous use of 5-Fu may cause severe side effects. The goal of this study was to investigate the effectiveness of Sarcodon aspratus polysaccharides (SATP) in alleviating 5-Fu-induced toxicity in Lewis tumor-bearing mice. Lewis tumor-bearing mice were treated with saline, SATP, 5-Fu or 5-Fu + SATP. The results indicated that compared to the 5-Fu group, the 5-Fu + SATP group showed effective amelioration of the liver, kidney and small intestine injury caused by 5-Fu and decreases in the levels of related biochemical indicators, such as aspartate aminotransferase (AST), alanine aminotransferase (ALT) and urea nitrogen (BUN). Additionally, the combination therapy enhanced the quality of life and immune organ indexes of mice. Further mechanistic studies indicated that the 5-Fu + SATP group showed a decrease in hepatotoxicity caused by 5-Fu via a reduction in the levels of interleukin-1ß (IL-1ß), an increase in the expression of Bcl-2 and decreases in the expression of p-p38, p-JNK and Bax. Collectively, the results indicated that SATP could significantly alleviate the toxicity of 5-Fu in Lewis tumor-bearing mice and showed the hepatoprotective capability of SATP via its effect on the expression levels of inflammatory factors and components of the MAPK/P38/JNK pathway, which shows that it may be a potential adjuvant for the chemotherapeutic drug 5-Fu in cancer treatment.


Subject(s)
Basidiomycota/chemistry , Fluorouracil/pharmacology , Fungal Polysaccharides/chemistry , Fungal Polysaccharides/pharmacology , Animals , Carcinoma, Lewis Lung , Cell Line, Tumor , Disease Models, Animal , Drug Antagonism , Immunohistochemistry , Interleukin-1beta/blood , Male , Mice , Tumor Burden , Xenograft Model Antitumor Assays
3.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-733078

ABSTRACT

Objective To investigate the change of expression pattern of microRNA in the lung with acute lung injury (ALI)/acute respiratory distress syndrome(ARDS) induced by lipopolysaccharide (LPS),and to provide an evidence that microRNAs are involved in the pathogenesis of ALI/ARDS.Methods Twenty-four C57BL mice were randomly divided into control group and LPS treated group,12 mice in each group.The rats in LPS treated group were treated with intratracheal injection of LPS at a dose of 10 mg/kg body weight into the lung.The rats in control group were treated with the same dose of saline instead.All mice were sacrificed 24 hours after operation,the left lung was excised to measure the wet-to-dry weight (W/D) ratio,and the right upper lobe was stained with hematoxylin and eosin (HE).A microRNA microarray chip was used to profile miRNA expressions in the lung of rats in both LPS treated group and control group.Online software packages were used to predict the gene targeted by microRNAs.Results Compared with the control group,the LPS treated mice had obvious respiratory symptoms,the W/D ratio was significantly increased (P < 0.01),and the pathology was characterized with ALI/ARDS.The microarray chip results demonstrated that the expressions of 48 microRNAs were significantly changed in the ALI/ARDS mice.Among these miRNA,27 cases were up-regulated,21 cases were down-regulated.The target genes of these microRNAs might be involved in regulating the signal pathway of inflammation.Conclusions Some miRNAs express differently in the model of ALI/ARDS,and they may play an important role in pathophysiological process of ALI/ARDS.

SELECTION OF CITATIONS
SEARCH DETAIL
...